|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| C12N 9/02 | (2006.01) | ||
| A61K 38/44 | (2006.01) | ||
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 2900253 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13841917.1 |
| Date of filing the European patent application | 2013-09-27 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation | 2019-03-25 |
| (86) | Number | PCT/US2013/062268 |
| Date | 2013-09-27 |
| (87) | Number | WO 2014/052807 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 201261706615 P | 2012-09-27 | US |
| (72) |
UNDERWOOD, Mark, Y., US
|
| (73) |
Stillwaters Bioscience Group, LLC,
301 Brock Street Coppell, Texas 75019,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Išsėtinės sklerozės simptomų palengvinimo būdai apoekvorino turinčių kompozicijų pagrindu |
| METHODS FOR ALLEVIATING SYMPTOMS OF MULTIPLE SCLEROSIS BASED ON APOAEQUORIN-CONTAINING COMPOSITIONS |
| Payment date | Validity (years) | Amount | |
| 2024-09-16 | 12 | 289.00 EUR |
| 2025-09-27 |